# ![@SatellosBio Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1453811169806913538.png) @SatellosBio Satellos Bioscience

Satellos Bioscience posts on X about $mscl, $msclf, we are, ceo the most. They currently have [---] followers and [---] posts still getting attention that total [-----] engagements in the last [--] hours.

### Engagements: [-----] [#](/creator/twitter::1453811169806913538/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1453811169806913538/c:line/m:interactions.svg)

- [--] Week [-----] +286%
- [--] Month [-----] -0.81%
- [--] Months [------] +73%
- [--] Year [------] +15%

### Mentions: [--] [#](/creator/twitter::1453811169806913538/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1453811169806913538/c:line/m:posts_active.svg)

- [--] Months [--] -19%
- [--] Year [--] +209%

### Followers: [---] [#](/creator/twitter::1453811169806913538/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1453811169806913538/c:line/m:followers.svg)

- [--] Week [---] +1.30%
- [--] Month [---] +2.50%
- [--] Months [---] +11%
- [--] Year [---] +20%

### CreatorRank: [---------] [#](/creator/twitter::1453811169806913538/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1453811169806913538/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[finance](/list/finance)  13% [travel destinations](/list/travel-destinations)  6% [exchanges](/list/exchanges)  4% [countries](/list/countries)  4% [stocks](/list/stocks)  2% [pga golfers](/list/pga-golfers)  1% [financial services](/list/financial-services)  1%

**Social topic influence**
[$mscl](/topic/$mscl) #1, [$msclf](/topic/$msclf) #2, [we are](/topic/we-are) 11%, [ceo](/topic/ceo) 9%, [science](/topic/science) 8%, [financial](/topic/financial) 7%, [$msle](/topic/$msle) #1, [stem](/topic/stem) 6%, [in the](/topic/in-the) 6%, [company](/topic/company) 4%

**Top accounts mentioned or mentioned by**
[@mrudnickiohri](/creator/undefined) [@mdaorg](/creator/undefined) [@franksatellos](/creator/undefined) [@tsxtsxv](/creator/undefined) [@guggsecurities](/creator/undefined) [@cureduchenne](/creator/undefined) [@worldmusclesoc](/creator/undefined) [@usfda](/creator/undefined) [@ddnewsonlines](/creator/undefined) [@riconferences](/creator/undefined) [@treatnmd](/creator/undefined) [@ottawacitizens](/creator/undefined) [@oppenheimer](/creator/undefined) [@cgdriven](/creator/undefined) [@morganstanley](/creator/undefined) [@satellos](/creator/undefined) [@financialpost](/creator/undefined) [@naturecomms](/creator/undefined) [@cihrirsc](/creator/undefined) [@pipersandler](/creator/undefined)

**Top assets mentioned**
[Morgan Stanley (MS)](/topic/morgan-stanley)
### Top Social Posts
Top posts by engagements in the last [--] hours

"Were excited to be on site at @TREAT_NMD [----] as a proud sponsor of the neuromuscular community. If youre here come visit us at Booth #15. Wed love to connect and share more about our approach to #muscleregeneration. #TREATNMDConference26 $MSLE $MSCL"  
[X Link](https://x.com/SatellosBio/status/2021251348512076156)  2026-02-10T15:54Z [---] followers, [---] engagements


"Science is stronger with women in it. Today we celebrate the women at Satellos and everywhere whose curiosity expertise and multi-processing skills are driving discovery and shaping the future. Heres to the next generation of women and girls in science. #GirlsInScience #WomenInScience #STEM #EveryVoiceInScience $MSLE $MSCL"  
[X Link](https://x.com/SatellosBio/status/2021632538662289771)  2026-02-11T17:08Z [---] followers, [---] engagements


"Turning real biology into real progress. Thats what today looks like at Satellos. Explore our #MuscleRegeneration $MSCL $MSCLF http://satellos.com/science http://satellos.com/science"  
[X Link](https://x.com/SatellosBio/status/2013975642157494393)  2026-01-21T14:03Z [---] followers, [----] engagements


"Weve reached an important milestone on our journey toward a potential Nasdaq listing with the completion of our share consolidation. Read full details #MuscleRegeneration $MSCL $MSCLF https://tinyurl.com/82ztkr3d https://tinyurl.com/82ztkr3d"  
[X Link](https://x.com/SatellosBio/status/2016507062889390147)  2026-01-28T13:42Z [---] followers, [----] engagements


"Satellos announced today that its common shares have been approved for listing on the Nasdaq Stock Market LLC and have commenced trading under the ticker MSLE. The Companys common shares continue to trade on TSX under MSCL. More here: $MSLE $MSCL #MuscleRegeneration https://tinyurl.com/5brx8yuw https://tinyurl.com/5brx8yuw"  
[X Link](https://x.com/SatellosBio/status/2019782985642320085)  2026-02-06T14:39Z [---] followers, [---] engagements


"Satellos will be participating in a fireside chat at the @GuggSecurities Emerging Outlook: Biotech Summit [----] in NYC on Feb. [--] at [--] a.m. ET. We look forward to sharing our recent progress and the momentum behind SAT-3247 our investigational therapy for people living with #Duchenne muscular dystrophy. Full details here: $MSLE $MSCL #MuscleRegeneration https://ir.satellos.com/news/news-details/2026/Satellos-to-Participate-in-the-Guggenheim-Securities-Emerging-Outlook-Biotech-Summit-2026/default.aspx"  
[X Link](https://x.com/SatellosBio/status/2021211840307437933)  2026-02-10T13:17Z [---] followers, [---] engagements


"Satellos announced today that the first participant has been dosed in BASECAMP a three-month randomized double-blind placebo-controlled proof-of-concept Phase [--] pediatric study of SAT-3247 for #Duchenne muscular dystrophy. Full details here: #MuscleRegeneration $MSCL $MSLE https://tinyurl.com/569d37xm https://tinyurl.com/569d37xm"  
[X Link](https://x.com/SatellosBio/status/2021918915438289070)  2026-02-12T12:06Z [---] followers, [----] engagements


"Great to be at @GuggSecurities Emerging Outlook: Biotech Summit [----] today connecting with investors and sharing more about Satellos work in #MuscleRegeneration. Thanks to everyone who took the time to connect. $MSCL $MSLE"  
[X Link](https://x.com/SatellosBio/status/2021985010753187861)  2026-02-12T16:29Z [---] followers, [---] engagements


"We will be presenting and participating in key investor conferences this September in New York City. We will be discussing the additional preclinical data weve disclosed over the summer as well as the advancement of our lead drug candidate SAT-3247 into clinical trials. SAT-3247 is in development as an oral small molecule medicine to restore muscle regeneration in #Duchenne #musculardystrophy and other degenerative muscle diseases and conditions. Join us at: ..    🗓 Date: Wednesday September 11th at 8:00 a.m. ET 🔥 Format: Fireside Chat   🗓 Date: Thursday September 19th at 9:45 a.m. ET 🔥"  
[X Link](https://x.com/SatellosBio/status/1831655018094617070)  2024-09-05T11:26Z [---] followers, [---] engagements


"We are thrilled to announce the upcoming presentation of data showing treatment of DMD canines with SAT-3247 improved measures of strength to near normal levels. Key highlights include: 🔹 Significant improvements in muscle morphology and regeneration across key muscle groups including the diaphragm quadriceps and calf. 🔹 Treated animals demonstrated muscle function returning to near-normal levels when compared to historical data 🔹 No adverse events or significant changes in clinical chemistry were observed after four months of daily oral treatment of SAT-3247. 🔹 Trends indicate lower"  
[X Link](https://x.com/SatellosBio/status/1841082570076778744)  2024-10-01T11:47Z [---] followers, [----] engagements


"So cool to see our cofounder and CSO @MRudnickiOHRI featured in the Ottawa Citizen A decade ago Dr. Rudnicki made a groundbreaking discovery in Duchenne muscular dystrophy research that changed the understanding of the disease. Today that breakthrough has paved the way for the development of a lead drug candidate SAT-3247 now entering clinical trials bringing us closer to delivering transformative therapies to patients. 📖 Read the @OttawaCitizens feature and watch his interview here: #muscledisease #musculardystrophy #Duchenne #smallmolecule #raredisease #rarediseases #regenerativemedicine"  
[X Link](https://x.com/SatellosBio/status/1861481702146912546)  2024-11-26T18:46Z [---] followers, [----] engagements


"Satellos will participate in @Oppenheimer Movers in Rare Disease Summit on December [--] [----] in New York City. Our CEO @frank_satellos will participate in a fireside chat at 9:50 am ET titled Polypharmacy in DMD and Neuromuscular Disease. Read the release here: $MSCL.to $MSCLF #raredisease #rarediseases #smallmolecule #regenmed #regenerativemedicine #Duchenne #musculardystrophy #DMD #Biotech https://ir.satellos.com/news/news-details/2024/Satellos-to-Participate-in-Oppenheimer-Movers-in-Rare-Disease-Summit/default.aspx"  
[X Link](https://x.com/SatellosBio/status/1863949197344698752)  2024-12-03T14:11Z [---] followers, [----] engagements


"Were excited to announce a major milestone in our clinical journey The first participant with Duchenne muscular dystrophy has been dosed in the Phase 1b trial of SAT-3247. This marks an important step forward in exploring the potential of our first-in-class small molecule drug candidate to improve muscle regeneration for those living with devastating muscle diseases. Read the release here: #muscledisease #musculardystrophy #Duchenne #smallmolecule #raredisease #rarediseases #regenerativemedicine #regenmed #clinicaltrial #clinicaltrials"  
[X Link](https://x.com/SatellosBio/status/1866817248784159156)  2024-12-11T12:08Z [---] followers, [----] engagements


"Excited to be heading to San Antonio this Thursday for the @CureDuchenne FUTURES National Conference Our CEO Frank Gleeson will be speaking in the New Therapeutic Approaches session on Sat. May [--] at p.m. CT. Also be sure to stop by Booth #12 and say hello 👉Register here: $MSCL $MSCLF #CureDuchenne https://web.cvent.com/event/3d756dbc-811a-4700-954e-ef31538e1a21/summary https://web.cvent.com/event/3d756dbc-811a-4700-954e-ef31538e1a21/summary"  
[X Link](https://x.com/SatellosBio/status/1925274096507437436)  2025-05-21T19:34Z [---] followers, [---] engagements


"Satellos will present at Canaccord Genuitys (@CG_Driven) 45th Annual Growth Conference taking place Aug. [----] at the InterContinental Boston. 📅 Aug. [--] 12:3012:55 p.m. ET 📍Abigail Adams C Well also be available for one-on-one investor meetings. More here: $MSCL $MSCLF https://tinyurl.com/y92ad9dp https://tinyurl.com/y92ad9dp"  
[X Link](https://x.com/SatellosBio/status/1952704488621363289)  2025-08-05T12:13Z [---] followers, [---] engagements


"Satellos was honored to participate in the @MorganStanley Global Healthcare Conference in New York City. Were working to bring a new oral approach for #Duchenne muscular dystrophy forward and value the chance to share our progress and whats next. 👉Listen to the fireside chat: #MuscleRegeneration $MSCLF $MSCL https://tinyurl.com/nu679c2c https://tinyurl.com/nu679c2c"  
[X Link](https://x.com/SatellosBio/status/1965829095088091447)  2025-09-10T17:25Z [---] followers, [---] engagements


"The Satellos team is looking forward to participating in the 30th Annual Congress of the @WorldMuscleSoc in Vienna Oct. [---]. Dont miss our scientific poster presentations including a late-breaking poster on our Phase 1a/b study. Details here: Be sure to stop by booth #12 to meet our team and learn more about our mission to restore #muscleregeneration in #Duchenne. #WMS2025 $MSCL $MSCLF https://tinyurl.com/2s3n9txx https://tinyurl.com/2s3n9txx https://tinyurl.com/2s3n9txx https://tinyurl.com/2s3n9txx"  
[X Link](https://x.com/SatellosBio/status/1972620228770058728)  2025-09-29T11:11Z [---] followers, [--] engagements


"#DuchenneNews: The@US_FDA as well as other global regulatory agencies have cleared Satellos to initiate a Phase [--] study of SAT-3247 in ambulatory children with Duchenne muscular dystrophy. Full details here: #MuscleRegeneration $MSCL $MSCLF https://tinyurl.com/yck6z5sx https://tinyurl.com/yck6z5sx"  
[X Link](https://x.com/SatellosBio/status/1998364565663514729)  2025-12-09T12:10Z [---] followers, [----] engagements


"Join us tomorrow Frank Gleeson Founder & CEO will present live - 3:30pm $MSCL https://www.prnewswire.com/news-releases/satellos-bioscience-to-webcast-live-at-life-sciences-investor-forum-december-16th-301444949.html https://www.prnewswire.com/news-releases/satellos-bioscience-to-webcast-live-at-life-sciences-investor-forum-december-16th-301444949.html"  
[X Link](https://x.com/SatellosBio/status/1471177956374552578)  2021-12-15T17:58Z [---] followers, [--] engagements


"We are pleased to announce a scientific research agreement with Universit de Sherbrooke #raredisease #regenerativemedicine $MSCL https://www.newsfilecorp.com/release/107772 https://www.newsfilecorp.com/release/107772"  
[X Link](https://x.com/SatellosBio/status/1471486053496328205)  2021-12-16T14:23Z [---] followers, [--] engagements


"Click here to read Satellos Bioscience CEO Frank Gleeson's letter to shareholders. #raredisease #regenerativemedicine $MSCL https://www.newsfilecorp.com/release/111106 https://www.newsfilecorp.com/release/111106"  
[X Link](https://x.com/SatellosBio/status/1485655805105954821)  2022-01-24T16:48Z [---] followers, [--] engagements


"Join us for an investor #webinar featuring @Satellos CEO Frank Gleeson hosted by Radius Research at 12:30pm ET. Register here #regenerativemedicine $MSCL #SatellosBio https://bit.ly/3uwnP8A https://bit.ly/3uwnP8A"  
[X Link](https://x.com/SatellosBio/status/1491388661501472770)  2022-02-09T12:29Z [---] followers, [--] engagements


"Satellos CSO @MRudnickiOHRI will speak at @DDNewsOnlines webinar to highlight his labs work on discovering druggable regulators of muscle stem #cell #regeneration and repair. Register here. $MSCL"  
[X Link](https://x.com/SatellosBio/status/1508791080472481799)  2022-03-29T13:00Z [---] followers, [--] engagements


"Satellos Bioscience to Webcast Live at @RIConferences on June 23rd [----]. Register here: $MSCL #LifeSciencesInvestorForum #VirtualInvestorConferences"  
[X Link](https://x.com/SatellosBio/status/1538984995271782400)  2022-06-20T20:39Z [---] followers, [--] engagements


"Satellos was featured in the @financialpost. Please read the article here: $MSCL https://financialpost.com/business-trends/satellos-bioscience-pursues-a-revolutionary-approach-to-treat-muscle-degeneration-give-new-hope-to-patients-and-parents https://financialpost.com/business-trends/satellos-bioscience-pursues-a-revolutionary-approach-to-treat-muscle-degeneration-give-new-hope-to-patients-and-parents"  
[X Link](https://x.com/SatellosBio/status/1539644957899853828)  2022-06-22T16:22Z [---] followers, [--] engagements


"Satellos Bioscience Co-Founder and Chief Scientific Officer @MRudnickiOHRI Published in @NatureComms. Read the full release: $MSCL #Duchenne"  
[X Link](https://x.com/SatellosBio/status/1547251006039212033)  2022-07-13T16:06Z [---] followers, [--] engagements


"Satellos Bioscience Co-Founder and Chief Scientific Officer @MRudnickiOHRI Awarded Significant #Grant from the @CIHR_IRSC. More details: $MSCL #Duchenne #MuscularDystrophy #Bioscience"  
[X Link](https://x.com/SatellosBio/status/1551613360415784960)  2022-07-25T17:00Z [---] followers, [--] engagements


"Read the full release here: $MSCL $MSCLF https://www.newsfilecorp.com/release/168091/Satellos-Bioscience-Announces-2023-Q1-Financial-Results-and-Operational-Highlights https://www.newsfilecorp.com/release/168091/Satellos-Bioscience-Announces-2023-Q1-Financial-Results-and-Operational-Highlights"  
[X Link](https://x.com/SatellosBio/status/1663927320338464770)  2023-05-31T15:16Z [---] followers, [---] engagements


"Satellos has received Orphan Drug Designation from the U.S. FDA for SAT-3153. Read the full release here: $MSCL $MSCLF https://www.newsfilecorp.com/release/175782 https://www.newsfilecorp.com/release/175782"  
[X Link](https://x.com/SatellosBio/status/1686744615125204992)  2023-08-02T14:23Z [---] followers, [---] engagements


"We are looking forward to presenting next Tuesday and participating in 1x1 meetings at the Stifel [----] Healthcare Conference taking place next week in NYC. See the release for #webcast info: $MSCL #MuscleRegeneration #Duchenne #MuscleDystrophy https://satellos.com/2023/11/02/satellos-to-present-at-the-stifel-2023-healthcare-conference/ https://satellos.com/2023/11/02/satellos-to-present-at-the-stifel-2023-healthcare-conference/"  
[X Link](https://x.com/SatellosBio/status/1721900924782928275)  2023-11-07T14:42Z [---] followers, [---] engagements


"We are looking forward to presenting at the @Piper_Sandler 35th Annual Healthcare Conference and participating in 1x1 meetings. See the release for #webcast info: $MSCL #MuscleRegeneration #Duchenne #MuscleDystrophy https://www.businesswire.com/news/home/20231120828119/en/ https://www.businesswire.com/news/home/20231120828119/en/"  
[X Link](https://x.com/SatellosBio/status/1726586092064047469)  2023-11-20T12:59Z [---] followers, [---] engagements


"Its hard to be a biotech if you're not an optimist. Our CEO Frank Gleeson shares reasons to be positive about biotech and why the most important thing is the work we do to help patients. Here's the chat w/@JonahComstock of @pharmaphorum at #JPM24: https://pharmaphorum.com/rd/jp-morgan-2024-frank-gleeson https://pharmaphorum.com/rd/jp-morgan-2024-frank-gleeson"  
[X Link](https://x.com/SatellosBio/status/1760654447233884452)  2024-02-22T13:15Z [---] followers, [---] engagements


"We were proud to bring together representatives from all [--] sites across eight countries for the Basecamp Investigator Meeting in Milan Italy last week supporting preparation for our Phase [--] study of SAT-3247 in children with #Duchenne. With [--] attendees from our site teams CRO and vendor partners the collaboration set a strong foundation for the climb ahead. Were energized by the momentum and ready to move toward trial initiation. #MuscleRegeneration $MSCL $MSCLF"  
[X Link](https://x.com/SatellosBio/status/1993021405311762757)  2025-11-24T18:18Z [---] followers, [---] engagements


"Our Q3 financials and operational highlights are available now: #Drugdevelopment #regenerativemedicine $MSCL https://www.newsfilecorp.com/release/105602 https://www.newsfilecorp.com/release/105602"  
[X Link](https://x.com/SatellosBio/status/1465437725809688580)  2021-11-29T21:49Z [---] followers, [--] engagements


"Satellos is on site at the @MDAorg Clinical and Scientific Conference sharing our latest developments on SAT-3153. Learn more here: $MSCL $MSCLF https://satellos.com/2023/03/19/satellos-to-present-at-annual-mda-clinical-and-scientific-conference-and-insights-in-research-investor-summit/ https://satellos.com/2023/03/19/satellos-to-present-at-annual-mda-clinical-and-scientific-conference-and-insights-in-research-investor-summit/"  
[X Link](https://x.com/SatellosBio/status/1638240620354445315)  2023-03-21T18:06Z [---] followers, [----] engagements


"Were pleased to welcome Elizabeth Williams CPA CA as CFO and to share that Warren Whitehead CPA CMA is now Head of Corporate Strategy. Liz has nearly [--] years of experience working with publicly listed biotechs in both Canada and U.S. $MSCL $MSCLF https://www.newsfilecorp.com/release/179361 https://www.newsfilecorp.com/release/179361"  
[X Link](https://x.com/SatellosBio/status/1699139332131652084)  2023-09-05T19:15Z [---] followers, [---] engagements


"Satellos Discloses Drug Target and Provides Development Update on #Duchenne Muscular Dystrophy Program Read the release: Sign up to view the Stifel presentation: $MSCL $MSCLF https://wsw.com/webcast/stifel83/register.aspxconf=stifel83&page=mscl.v&url=https://wsw.com/webcast/stifel83/mscl.v/2360662 https://www.businesswire.com/news/home/20231114699220/en/Satellos-Discloses-Drug-Target-and-Provides-Development-Update-on-Duchenne-Muscular-Dystrophy-Program https://wsw.com/webcast/stifel83/register.aspxconf=stifel83&page=mscl.v&url=https://wsw.com/webcast/stifel83/mscl.v/2360662"  
[X Link](https://x.com/SatellosBio/status/1724423357716627957)  2023-11-14T13:45Z [---] followers, [---] engagements


"We are pleased to announce that Satellos has received conditional approval to graduate to the Toronto Stock Exchange (TSX). $MSCL $MSCLF #muscledisease #musculardystrophy #Duchenne https://ir.satellos.com/news/news-details/2024/Satellos-Receives-Conditional-Approval-to-Graduate-to-the-Toronto-Stock-Exchange/default.aspx https://ir.satellos.com/news/news-details/2024/Satellos-Receives-Conditional-Approval-to-Graduate-to-the-Toronto-Stock-Exchange/default.aspx"  
[X Link](https://x.com/SatellosBio/status/1747242472751923422)  2024-01-16T13:00Z [---] followers, [---] engagements


"We are excited to announce that Satellos will begin trading on the Toronto Stock Exchange (TSX) as of February [--] [----]. $MSCL $MSCLF #Duchenne #musculardystrophy #rarediseases #biotech #innovation https://ir.satellos.com/news/news-details/2024/Satellos-to-Commence-Trading-on-the-Toronto-Stock-Exchange/default.aspx https://ir.satellos.com/news/news-details/2024/Satellos-to-Commence-Trading-on-the-Toronto-Stock-Exchange/default.aspx"  
[X Link](https://x.com/SatellosBio/status/1757760948767694891)  2024-02-14T13:37Z [---] followers, [---] engagements


"Satellos Presents Positive Preclinical Efficacy Data for SAT-3247 at the [----] MDA Clinical & Scientific Conference $MSCL @MDAorg #MDAconference #Duchenne #musculardystrophy #FSHD https://ir.satellos.com/news/news-details/2024/Satellos-Presents-Positive-Preclinical-Efficacy-Data-for-SAT-3247-at-the-2024-MDA-Clinical--Scientific-Conference/default.aspx https://ir.satellos.com/news/news-details/2024/Satellos-Presents-Positive-Preclinical-Efficacy-Data-for-SAT-3247-at-the-2024-MDA-Clinical--Scientific-Conference/default.aspx"  
[X Link](https://x.com/SatellosBio/status/1764646140438368426)  2024-03-04T13:36Z [---] followers, [---] engagements


""It's incredibly neat biology." @neurology_live caught up with Satellos CEO Frank Gleeson at the #MDAconference to discuss #Duchenne muscular dystrophy and how SAT-3247 works to combat the loss of dystrophin to restore muscle regeneration. $MSCL https://www.neurologylive.com/view/mechanism-action-sat-3247-muscular-dystrophy-frank-gleeson https://www.neurologylive.com/view/mechanism-action-sat-3247-muscular-dystrophy-frank-gleeson"  
[X Link](https://x.com/SatellosBio/status/1772268358408265951)  2024-03-25T14:24Z [---] followers, [----] engagements


"Satellos to Present at the [----] Bloom Burton & Co. Healthcare Investor Conference $MSCL $MSCLF #biotech #musculardystrophy #Duchenne #smallmolecule #raredisease #rarediseases https://ir.satellos.com/news/news-details/2024/Satellos-to-Present-at-the-2024-Bloom-Burton--Co.-Healthcare-Investor-Conference/default.aspx https://ir.satellos.com/news/news-details/2024/Satellos-to-Present-at-the-2024-Bloom-Burton--Co.-Healthcare-Investor-Conference/default.aspx"  
[X Link](https://x.com/SatellosBio/status/1778045080110239773)  2024-04-10T12:59Z [---] followers, [---] engagements


"Join Satellos CEO Frank Gleeson (@frank_satellos) + CFO Elizabeth Williams (@CdnBioCFO) for a live webinar hosted by Radius Research this Thurs June [--] @ 4PM ET. Hear the latest on SAT-3247 in #Duchenne+ whats ahead for $MSCL. 🔗Register: $MSCLF #muscleregeneration https://tinyurl.com/4k6kbryv https://tinyurl.com/4k6kbryv https://tinyurl.com/4k6kbryv https://tinyurl.com/4k6kbryv"  
[X Link](https://x.com/SatellosBio/status/1930245572407038213)  2025-06-04T12:49Z [---] followers, [---] engagements


"Very pleased to support our partners at Jesse's Journey alongside the Mike Weir Foundation on this #GivingTuesdayCa. Join in on the fight to #DefeatDuchenne $MSCL Inspired by the Mike Weir Foundation @mweirsy @SatellosBio has generously donated $5000 to support our #GivingTuesdayCa matched gift appeal. That means you can TRIPLE your investment in the fight to #DefeatDuchenne. Donate by midnight: https://t.co/1TlXXxoBdi. https://t.co/TBCDXT73Pw Inspired by the Mike Weir Foundation @mweirsy @SatellosBio has generously donated $5000 to support our #GivingTuesdayCa matched gift appeal. That means"  
[X Link](https://x.com/SatellosBio/status/1465793022495531010)  2021-11-30T21:21Z [---] followers, [--] engagements


"$MSCL $MSCLF I did a write up on @SatellosBio. They've got a whole different approach to treating muscular dystrophies (with a lead indication in #DMD) based on research showing the role muscle stem cells play. I did a write up on @SatellosBio. They've got a whole different approach to treating muscular dystrophies (with a lead indication in #DMD) based on research showing the role muscle stem cells play"  
[X Link](https://x.com/SatellosBio/status/1469015931745677316)  2021-12-09T18:47Z [---] followers, [--] engagements


"Founder and CEO Frank Gleeson will be presenting at the @RIConferences on March [--] [----] Tune in here at 1:30 pm EST $MSCL https://bit.ly/3vTISCv https://bit.ly/3vTISCv"  
[X Link](https://x.com/SatellosBio/status/1501626396547981313)  2022-03-09T18:30Z [---] followers, [--] engagements


"We've been selected to present at the Insights in Research Investor Summit & @MDAorg Clinical & Scientific Conference from March 13-16. Dr. Mitchell will highlight the advancements of Satellos' skeletal #muscle regeneration #technology. Learn more $MSCL https://bit.ly/3hYISZP https://bit.ly/3hYISZP"  
[X Link](https://x.com/SatellosBio/status/1501984238228451335)  2022-03-10T18:12Z [---] followers, [--] engagements


"We are excited to announce further development in our joint venture with NW PharmaTech The joint venture will focus on the invention development and scientific validation of oral formulations of sleep aids utilizing our OralTrans technology. Get the details here 👇 $MSCL"  
[X Link](https://x.com/SatellosBio/status/1502288204804026370)  2022-03-11T14:19Z [---] followers, [--] engagements


"Satellos was selected to give oral and poster presentations at the [----] Insights in Research Investor Summit and @MDAorg Clinical & Scientific Conference. Dr. Mitchell will be presenting our game-changing science for rebuilding #muscle in #Duchenne. Learn more. 👇 $MSCL"  
[X Link](https://x.com/SatellosBio/status/1503449680507641857)  2022-03-14T19:15Z [---] followers, [--] engagements


"Satellos' CSO @MRudnickiOHRI was featured on @DDNewsOnline's webinar. Dr. Rudnicki presented his labs' work on how they're mobilizing muscle stem cells to treat #Duchenne #musculardystrophy. Watch the recording with the link below $MSCL https://www.bigmarker.com/labx-media-group/The-Promise-and-Reality-of-Stem-Cell-Researchbmid=9e1240f29cc7 https://www.bigmarker.com/labx-media-group/The-Promise-and-Reality-of-Stem-Cell-Researchbmid=9e1240f29cc7"  
[X Link](https://x.com/SatellosBio/status/1511018511044337670)  2022-04-04T16:31Z [---] followers, [--] engagements


"Satellos will be attending the Scottsdale Capital Event taking place from April 22-24 [----]. CEO @frank_satellos has a full schedule connecting and sharing Satellos' story with active top-level investors. More details on the event: $MSCL #CEM"  
[X Link](https://x.com/SatellosBio/status/1516830758454894592)  2022-04-20T17:26Z [---] followers, [--] engagements


"Dr. Ryan Mitchell will present a poster on our groundbreaking science at the @EMBOevents workshop in France from April 25-26. We look forward to presenting our pioneering approach to #therapeutics development for #Duchenne Muscular Dystrophy. Details: $MSCL #EMBOworkshop2022"  
[X Link](https://x.com/SatellosBio/status/1517173788168704000)  2022-04-21T16:09Z [---] followers, [--] engagements


"We have been invited to present at the [----] @bloomburton Healthcare Investor Conference where CEO @frank_satellos will deliver a presentation & hold 1-on-1 meetings on May 2-3 from 8:30 am-4:30 pm. Join the live presentation virtually: $MSCL #BBHIC2022"  
[X Link](https://x.com/SatellosBio/status/1519019098809663489)  2022-04-26T18:22Z [---] followers, [--] engagements


"Accompanied by brilliant minds in the muscle regeneration space Dr. Ryan Mitchell presented Satellos' poster on our pioneering approach to therapeutics development for #Duchenne Muscular Dystrophy at the #EMBOworkshop2022. View our poster here: $MSCL"  
[X Link](https://x.com/SatellosBio/status/1519749790384369669)  2022-04-28T18:46Z [---] followers, [--] engagements


"Satellos had a transformative [----]. We've made breakthrough proprietary discoveries that will assist in helping those suffering from #Duchenne muscular dystrophy. Our work continues where there's an incredible opportunity on the horizon. Read the year-end highlights: $MSCL"  
[X Link](https://x.com/SatellosBio/status/1521915561193660422)  2022-05-04T18:12Z [---] followers, [--] engagements


".@CureDuchenne has a great initiative for families with a #Duchenne diagnosis. They host a safe space for families to engage with other families & members of the community. If this interests you register below. $MSCL"  
[X Link](https://x.com/SatellosBio/status/1522662558204792832)  2022-05-06T19:40Z [---] followers, [--] engagements


"Satellos announces Q1 [----] financial results and operational highlights. Learn more: $MSCL"  
[X Link](https://x.com/SatellosBio/status/1531763305252917248)  2022-05-31T22:23Z [---] followers, [--] engagements


"We have been invited to the 12th annual @theLDMicro Invitational on June [--] at [--] AM PT. As we continue to make great strides in the battle against Duchenne opportunities like LD Micro allow us to share our cutting-edge science with important stakeholders. Register here: $MSCL"  
[X Link](https://x.com/SatellosBio/status/1532078185151549441)  2022-06-01T19:14Z [---] followers, [--] engagements


"Satellos Bioscience Inc. to present at @IAmBiotech International Convention [----]. Dr. Ryan Mitchell PhD and Director of Business Development to highlight Satellos novel muscle regeneration technology on June [--] at 11:15 AM PDT. Learn more: $MSCL"  
[X Link](https://x.com/SatellosBio/status/1536746726022713349)  2022-06-14T16:25Z [---] followers, [--] engagements


"Satellos Bioscience Co-Founder and Chief Scientific Officer Dr. Michael Rudnicki is Officially Recognized as a Fellow of the @royalsociety. Learn more about Dr. Rudnicki's #accomplishment. $MSCL #Duchenne #DMD"  
[X Link](https://x.com/SatellosBio/status/1539700007191752705)  2022-06-22T20:01Z [---] followers, [--] engagements


".@MRudnickiOHRI was featured in the @OttawaCitizen. His research has transformed the understanding of #muscleregeneration & has led to novel stem cell-based approaches to treating #DMD. Read the full article: $MSCL https://ottawacitizen.com/news/local-news/it-gives-me-goosebumps-renowned-ottawa-scientist-michael-rudnicki-joins-royal-society https://ottawacitizen.com/news/local-news/it-gives-me-goosebumps-renowned-ottawa-scientist-michael-rudnicki-joins-royal-society"  
[X Link](https://x.com/SatellosBio/status/1540043724947865602)  2022-06-23T18:46Z [---] followers, [--] engagements


"Join us in recognizing #RareDiseaseDay Satellos is developing a novel drug SAT-3153 for the treatment of a rare disease named Duchenne Muscular Dystrophy. Learn more about #rarediseaseday here @rarediseaseday $MSCL $MSCLF https://www.rarediseaseday.org/ https://www.rarediseaseday.org/"  
[X Link](https://x.com/SatellosBio/status/1630556817762729989)  2023-02-28T13:13Z [---] followers, [--] engagements


"Satellos has closed a $55M financing with participation from leading healthcare specialized institutional investors. Read the full release here: $MSCL $MSCLF https://satellos.com/2023/05/17/satellos-bioscience-closes-55m-financing-to-support-development-of-its-lead-drug-candidate-for-duchenne-muscular-dystrophy/ https://satellos.com/2023/05/17/satellos-bioscience-closes-55m-financing-to-support-development-of-its-lead-drug-candidate-for-duchenne-muscular-dystrophy/"  
[X Link](https://x.com/SatellosBio/status/1658943284889174016)  2023-05-17T21:11Z [---] followers, [----] engagements


"@SatellosBio will be in Boston for the @BIOConvention Interested parties can connect using the official partnering app in order to learn more. $MSCL $MSCLF"  
[X Link](https://x.com/SatellosBio/status/1664336866408013824)  2023-06-01T18:23Z [---] followers, [---] engagements


"Today we announced our [----] Q3 financial results and operational highlights as well as the appointment of Michael Cross PhD MBA as Chief Business Officer. Welcome to the team Michael $MSCL #MuscleRegeneration #Duchenne #MuscleDystrophy https://satellos.com/2023/11/22/satellos-bioscience-announces-2023-q3-financial-results-and-operational-highlights/ https://satellos.com/2023/11/22/satellos-bioscience-announces-2023-q3-financial-results-and-operational-highlights/"  
[X Link](https://x.com/SatellosBio/status/1727305735955255670)  2023-11-22T12:39Z [---] followers, [---] engagements


"Satellos Announces Upcoming Presentations at the [----] MDA Clinical & Scientific Conference See the press release for details: $MSCL @MDAorg #MDAconference #Duchenne #FSHD #musculardystrophy https://ir.satellos.com/news/news-details/2024/Satellos-Announces-Upcoming-Presentations-at-the-2024-Muscular-Dystrophy-Association-Clinical--Scientific-Conference-26e373cd6/default.aspx https://ir.satellos.com/news/news-details/2024/Satellos-Announces-Upcoming-Presentations-at-the-2024-Muscular-Dystrophy-Association-Clinical--Scientific-Conference-26e373cd6/default.aspx"  
[X Link](https://x.com/SatellosBio/status/1759956481909334167)  2024-02-20T15:01Z [---] followers, [---] engagements


"We are proud to announce that @TSX_TSXV has recognized Satellos as a Top [--] TSX Venture Exchange company Read the release here: Learn more about the #Venture50 here: $MSCL #biotech #innovation #lifesciences http://www.tsx.com/Venture50 https://ir.satellos.com/news/news-details/2024/Satellos-Recognized-as-a-Top-50-TSX-Venture-Exchange-Company/default.aspx http://www.tsx.com/Venture50 https://ir.satellos.com/news/news-details/2024/Satellos-Recognized-as-a-Top-50-TSX-Venture-Exchange-Company/default.aspx"  
[X Link](https://x.com/SatellosBio/status/1760294209075200145)  2024-02-21T13:23Z [---] followers, [---] engagements


"We are looking forward to the #MDAconference which starts Sunday See the press release for more details on our poster and oral presentations: $MSCL @MDAorg #Duchenne #musculardystrophy #FSHD https://ir.satellos.com/news/news-details/2024/Satellos-Announces-Upcoming-Presentations-at-the-2024-Muscular-Dystrophy-Association-Clinical--Scientific-Conference-26e373cd6/default.aspx https://ir.satellos.com/news/news-details/2024/Satellos-Announces-Upcoming-Presentations-at-the-2024-Muscular-Dystrophy-Association-Clinical--Scientific-Conference-26e373cd6/default.aspx"  
[X Link](https://x.com/SatellosBio/status/1763564920837193871)  2024-03-01T14:00Z [---] followers, [---] engagements


"We are looking forward to participating in 1x1 meetings at the Leerink Partners Global Biopharma Conference [----] taking place next week in Miami. See the release for more info: $MSCL #Duchenne #musculardystrophy https://ir.satellos.com/news/news-details/2024/Satellos-to-Participate-in-the-Leerink-Partners-Global-Biopharma-Conference-2024/default.aspx https://ir.satellos.com/news/news-details/2024/Satellos-to-Participate-in-the-Leerink-Partners-Global-Biopharma-Conference-2024/default.aspx"  
[X Link](https://x.com/SatellosBio/status/1765039507869745547)  2024-03-05T15:39Z [---] followers, [---] engagements


"We are looking forward to presenting at Stifel [----] Virtual CNS Days and Cantor Virtual Muscular Dystrophy Symposium. See the release for more info: $MSCL #Duchenne #musculardystrophy https://ir.satellos.com/news/news-details/2024/Satellos-to-Present-at-Upcoming-Virtual-Investor-Conferences-in-March-and-April/default.aspx https://ir.satellos.com/news/news-details/2024/Satellos-to-Present-at-Upcoming-Virtual-Investor-Conferences-in-March-and-April/default.aspx"  
[X Link](https://x.com/SatellosBio/status/1768268299241189594)  2024-03-14T13:29Z [---] followers, [---] engagements


"Satellos Bioscience Announces [----] Year End Financial Results and Operational Highlights $MSCL $MSCLF #Duchenne #musculardystrophy #smallmolecule #regenmed https://ir.satellos.com/news/news-details/2024/Satellos-Bioscience-Announces-2023-Year-End-Financial-Results-and-Operational-Highlights/default.aspx https://ir.satellos.com/news/news-details/2024/Satellos-Bioscience-Announces-2023-Year-End-Financial-Results-and-Operational-Highlights/default.aspx"  
[X Link](https://x.com/SatellosBio/status/1772965399157526870)  2024-03-27T12:34Z [---] followers, [---] engagements


"We're delighted to be recognized by @tsx_tsxv as a #Venture50 company. We look forward to continuing our incredible momentum as we move from discovery to clinical-stage company. Learn more about our transformative approach to muscle regeneration: $MSCL http://www.satellos.com .@SatellosBio (TSX:MSCL) is developing new small molecule medicines that rethink the way degenerative muscle diseases are treated. With a share price appreciation of +95% $MSCL has ranked on this years #Venture50🥇 Explore the top #TSXV companies 👉 https://t.co/MBukMsro0T https://t.co/X5FBg0n5QC http://www.satellos.com"  
[X Link](https://x.com/SatellosBio/status/1775216529350824332)  2024-04-02T17:39Z [---] followers, [---] engagements


"#ICYMI: Our presentations at Stifel [----] Virtual CNS Days Cantor Virtual Muscular Dystrophy Symposium and Bloom Burton & Co. Healthcare Investor Conference can now be viewed on demand. Check them out at: $MSCL #Duchenne #musculardystrophy https://ir.satellos.com/overview/default.aspx https://ir.satellos.com/overview/default.aspx"  
[X Link](https://x.com/SatellosBio/status/1782780271521317342)  2024-04-23T14:35Z [---] followers, [---] engagements


"Today we announced our [----] Q1 financial results and operational highlights Read the release for more info: $MSCL #MuscleRegeneration #Duchenne #MuscleDystrophy https://ir.satellos.com/news/news-details/2024/Satellos-Bioscience-Announces-Q1-2024-Financial-Results-and-Operational-Highlights/default.aspx https://ir.satellos.com/news/news-details/2024/Satellos-Bioscience-Announces-Q1-2024-Financial-Results-and-Operational-Highlights/default.aspx"  
[X Link](https://x.com/SatellosBio/status/1790355949590585445)  2024-05-14T12:18Z [---] followers, [---] engagements


"With our #smallmolecule #regenerativemedicine approach Satellos is ringing in a new chapter in the treatment of devastating muscle diseases. 🔔💪 Thank you @tsx_tsxv for celebrating our graduation to the TSX $MSCL $MSCLF #Duchenne #musculardystrophy https://www.youtube.com/watchv=URi08_Iu3NE https://www.youtube.com/watchv=URi08_Iu3NE"  
[X Link](https://x.com/SatellosBio/status/1790817824996307188)  2024-05-15T18:53Z [---] followers, [---] engagements


"We are pleased to announce today the submission of a regulatory filing to commence a Phase [--] clinical trial with SAT-3247 and that weve successfully completed IND-enabling preclinical and toxicology studies Read the release for more details: $MSCL $MSCLF #Duchenne #musculardystrophy #clinicaltrial https://www.businesswire.com/news/home/20240711270123/en/ https://www.businesswire.com/news/home/20240711270123/en/"  
[X Link](https://x.com/SatellosBio/status/1811360246708707531)  2024-07-11T11:21Z [---] followers, [----] engagements


"$MSCL News: Today Satellos announced its financial results and corporate highlights for the fourth quarter. Full details here: #smallmolecule #regenerativemedicine #Duchenne https://ir.satellos.com/news/news-details/2025/Satellos-Reports-2024-Financial-Results-and-Highlights-Company-Progress/default.aspx https://ir.satellos.com/news/news-details/2025/Satellos-Reports-2024-Financial-Results-and-Highlights-Company-Progress/default.aspx"  
[X Link](https://x.com/SatellosBio/status/1904851489182343395)  2025-03-26T11:02Z [---] followers, [---] engagements


"$MSCL NEWS: Satellos announces first quarter financial results and recent company progress. Full details here: $MSCLF #Duchenne #MuscleRegeneration https://tinyurl.com/2vyrznbh https://tinyurl.com/2vyrznbh"  
[X Link](https://x.com/SatellosBio/status/1922247288971272659)  2025-05-13T11:07Z [---] followers, [---] engagements


"$MSCLNews: Today Satellos announced promising functional data from the Phase 1b open-label study of SAT-3247 in adults with #Duchennemuscular dystrophy. Full details here: $MSCLF #MuscleRegeneration https://tinyurl.com/2vrrv2dw https://tinyurl.com/2vrrv2dw"  
[X Link](https://x.com/SatellosBio/status/1925513695666516079)  2025-05-22T11:26Z [---] followers, [----] engagements


"Whats on our minds this week at Satellos 🧠 Muscle regeneration 📍 Urgent needs in #Duchenne The science of polarity Were always thinking about how to move the field forward by returning to the biology behind muscle repair. Learn more at $MSCL $MSCLF https://twitter.com/i/web/status/1942996527581921715 http://satellos.com https://twitter.com/i/web/status/1942996527581921715 http://satellos.com"  
[X Link](https://x.com/SatellosBio/status/1942996527581921715)  2025-07-09T17:17Z [---] followers, [---] engagements


"$MSCL News: Satellos announces its second quarter financial results and company updates. Read the press release: #Duchenne #MuscleRegeneration $MSCLF https://tinyurl.com/3kk9scvp https://tinyurl.com/3kk9scvp"  
[X Link](https://x.com/SatellosBio/status/1955588005990977806)  2025-08-13T11:11Z [---] followers, [----] engagements


"Why cant muscles repair themselves in #Duchenne muscular dystrophy Satellos uncovered whats missing and is studying an investigational approach designed to restore muscle regeneration. Watch the full video: #DecodingDuchenne #MuscleRegeneration $MSCL $MSCLF https://ir.satellos.com/ https://ir.satellos.com/"  
[X Link](https://x.com/SatellosBio/status/1970883791930425699)  2025-09-24T16:11Z [---] followers, [----] engagements


"Were proud to join this weekends @defeatduchenne Canada Family Forum in Toronto and to introduce the keynote speaker a reflection of our shared commitment to science collaboration and better outcomes for people living with #Duchenne. 🔗 $MSCL $MSCLF http://defeatduchenne.ca/news-and-events/events/2025-family-forum/ http://defeatduchenne.ca/news-and-events/events/2025-family-forum/"  
[X Link](https://x.com/SatellosBio/status/1981749790615519722)  2025-10-24T15:49Z [---] followers, [---] engagements


"The Satellos leadership team will participate in healthcare investor conferences next month in Boston and New York. We look forward to the conversations ahead. #Duchenne #MuscleRegeneration $MSCL $MSCLF https://ir.satellos.com/news/news-details/2025/Satellos-to-Participate-in-November-Investor-Conferences/default.aspx https://ir.satellos.com/news/news-details/2025/Satellos-to-Participate-in-November-Investor-Conferences/default.aspx"  
[X Link](https://x.com/SatellosBio/status/1983852039601062097)  2025-10-30T11:02Z [---] followers, [---] engagements


"$MSCL News: Were pleased to welcome Dr. Wildon Farwell as our new chief medical officer. Hes a physician and biotech leader with a deep commitment to advancing care in neuromuscular and rare diseases. Were lucky to have him on board. 🔗Full details here: $MSCLF #Duchenne #MuscleRegeneration https://ir.satellos.com/news/news-details/2025/Satellos-Appoints-Dr--Wildon-Farwell-as-Chief-Medical-Officer/default.aspx https://ir.satellos.com/news/news-details/2025/Satellos-Appoints-Dr--Wildon-Farwell-as-Chief-Medical-Officer/default.aspx"  
[X Link](https://x.com/SatellosBio/status/1945447708136792573)  2025-07-16T11:37Z [---] followers, [----] engagements


"(🔊sound on) Repair is possible if the biology is there to support it. Were developing a new kind of therapy for Duchenne muscular dystrophy built on the science of muscle stem cells. #Duchenne #MuscleRegeneration $MSCL $MSCLF http://satellos.com http://satellos.com"  
[X Link](https://x.com/SatellosBio/status/1950562929754923144)  2025-07-30T14:23Z [---] followers, [----] engagements


"(🔊sound on) The impact of #Duchenne muscular dystrophy is visible on the surface. But the root of it lies deeper.in how muscle fails to regenerate. Thats where were focused. #MuscleRegeneration $MSCL $MSCLF http://satellos.com http://satellos.com"  
[X Link](https://x.com/SatellosBio/status/1951285985158795369)  2025-08-01T14:16Z [---] followers, [----] engagements


"$MSCL News: Today we announced submission of an IND application to the @US_FDA along with parallel global regulatory filings to initiate a Phase [--] clinical trial of SAT-3247 in children with #Duchenne muscular dystrophy. Full details here: #MuscleRegeneration $MSCLF https://tinyurl.com/54kua8t5 https://tinyurl.com/54kua8t5"  
[X Link](https://x.com/SatellosBio/status/1970084348297646159)  2025-09-22T11:14Z [---] followers, [----] engagements


"$MSCL News: Today we announced new data demonstrating tolerability and initial exploratory efficacy in the Phase 1b open-label study of SAT-3247 in adults with #Duchenne muscular dystrophy at the @WorldMuscleSoc. More in todays release: #WMS2025 #WorldMuscleSociety #MuscleRegeneration $MSCLF https://tinyurl.com/yrj7v663 https://tinyurl.com/yrj7v663"  
[X Link](https://x.com/SatellosBio/status/1976645613883207699)  2025-10-10T13:46Z [---] followers, [---] engagements


"#Duchenne News: Today Satellos announced that the first patient has been dosed in LT-001 an open-label long-term follow-up study of SAT-3247 in adult males with Duchenne muscular dystrophy. Full details here: #MuscleRegeneration $MSCL $MSCLF https://tinyurl.com/satellos-fpd https://tinyurl.com/satellos-fpd"  
[X Link](https://x.com/SatellosBio/status/1980592371973910754)  2025-10-21T11:09Z [---] followers, [----] engagements


"Thank you to @mdnewstoday_ for highlighting Satellos and our progress toward a potential new treatment approach for #Duchenne muscular dystrophy. Read the full story: $MSCL $MSCLF https://musculardystrophynews.com/news/oral-therapy-moves-follow-strong-data-dmd-adults/ Dosing has begun in a long-term extension study testing Satellos Biosciences experimental oral therapy SAT-3247 in men with DMD. https://t.co/z8otMiK8pw #musculardystrophynews #musculardystrophy #musculardystrophycommunity #livingwithMD https://t.co/GC1AavQXCp"  
[X Link](https://x.com/SatellosBio/status/1988639454827872676)  2025-11-12T16:06Z [---] followers, [----] engagements


"Satellos has reported its Q3 [----] financial results and announced the appointment of Mark Nawacki to its Board of Directors. Read the full #MuscleRegeneration #Duchenne $MSCL $MSCLF https://tinyurl.com/mscl-Q3-25 https://tinyurl.com/mscl-Q3-25"  
[X Link](https://x.com/SatellosBio/status/1989305991406526955)  2025-11-14T12:14Z [---] followers, [---] engagements


"Grateful to be featured inScrip on our progress with SAT-3247 and our #muscleregeneration strategy to tackle #Duchenne. Phase [--] preparations are underway. Read more: $MSCLF $MSCL https://tinyurl.com/4dumt3ju https://tinyurl.com/4dumt3ju"  
[X Link](https://x.com/SatellosBio/status/1996975066362372445)  2025-12-05T16:08Z [---] followers, [----] engagements


"A question that sits at the center of our work. Explore more at #MuscleRegeneration #Duchenne $MSCL $MSCLF http://satellos.com http://satellos.com"  
[X Link](https://x.com/SatellosBio/status/2000943757815111864)  2025-12-16T14:59Z [---] followers, [---] engagements


"Today HHS announced that #Duchennemuscular dystrophy has been added to the recommended newborn screening panel. This is an important step toward helping families get answers earlier and begin care sooner. Read more: https://www.hhs.gov/press-room/secretary-kennedy-adds-duchenne-muscular-dystrophy-metachromatic-leukodystrophy-to-newborn-screenings.html https://www.hhs.gov/press-room/secretary-kennedy-adds-duchenne-muscular-dystrophy-metachromatic-leukodystrophy-to-newborn-screenings.html"  
[X Link](https://x.com/SatellosBio/status/2001014061962813797)  2025-12-16T19:38Z [---] followers, [---] engagements


"The reason behind the research. #MuscleRegeneration #Duchenne $MSCL $MSCLF Learn more at http://satellos.com http://satellos.com"  
[X Link](https://x.com/SatellosBio/status/2001673739860349254)  2025-12-18T15:19Z [---] followers, [----] engagements


"Looking back on a meaningful year and ahead to whats next. #MuscleRegeneration #Duchenne $MSCL $MSCLF http://www.satellos.com http://www.satellos.com"  
[X Link](https://x.com/SatellosBio/status/2003465626975625362)  2025-12-23T14:00Z [---] followers, [----] engagements


"#SatellosStories: Drew Scruggs came to clinical research through science but stayed because of the people. She studied chemistry in school and knew early on she wanted to work in medicine. As her career took shape she found her place in the rare neuromuscular community working closely with #Duchenne families investigators and site teams. What stays with you are the families Drew says. Every visit takes time away from school work and home. This is not a small ask and it should shape how trials are designed. Her experience in Duchenne has taught her that clinical research only works when it"  
[X Link](https://x.com/SatellosBio/status/2011469675532603881)  2026-01-14T16:05Z [---] followers, [---] engagements


"Were excited to welcome Antoinette Paone as Chief Development Officer & Head of Regulatory Affairs. Antoinette is an experienced development and regulatory leader with a strong track record across clinical development regulatory strategy and operational execution. She brings deep expertise spanning regulatory affairs quality CMC technical operations and program management. Read the full announcement: $MSCL $MSCLF https://tinyurl.com/4xxehhc6 https://tinyurl.com/4xxehhc6"  
[X Link](https://x.com/SatellosBio/status/2016845902711816564)  2026-01-29T12:08Z [---] followers, [---] engagements


"Satellos is heading to San Francisco for the @jpmorgan Healthcare Conferencenext week. With BASECAMP our Phase [--] trial of SAT-3247 in children with #Duchenne now underway we look forward to connecting with industry leaders and the investment community to discuss the year ahead. #JPM2026 #MuscleRegeneration $MSCL $MSCLF"  
[X Link](https://x.com/SatellosBio/status/2008910650253201586)  2026-01-07T14:36Z [---] followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing